首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   104篇
  免费   12篇
耳鼻咽喉   2篇
儿科学   6篇
妇产科学   7篇
基础医学   11篇
临床医学   9篇
内科学   22篇
皮肤病学   7篇
神经病学   6篇
特种医学   1篇
外科学   14篇
预防医学   13篇
眼科学   1篇
药学   9篇
肿瘤学   8篇
  2022年   2篇
  2021年   3篇
  2020年   3篇
  2019年   3篇
  2018年   5篇
  2017年   5篇
  2016年   5篇
  2015年   4篇
  2014年   5篇
  2013年   5篇
  2012年   8篇
  2011年   11篇
  2010年   8篇
  2009年   4篇
  2008年   3篇
  2007年   3篇
  2006年   6篇
  2005年   1篇
  2004年   3篇
  2003年   2篇
  2002年   2篇
  2001年   8篇
  2000年   3篇
  1999年   3篇
  1997年   1篇
  1996年   2篇
  1995年   1篇
  1991年   1篇
  1990年   3篇
  1989年   1篇
  1985年   2篇
排序方式: 共有116条查询结果,搜索用时 15 毫秒
1.
Aim The aim of this study was to analyse the characteristics of horseshoe tract formation in anal fistula. Method We retrospectively analysed the data from all consecutive patients who underwent surgery for an anal fistula from November 2004 to March 2011. A horseshoe tract was defined as a circumferential extension connecting both sides of the anorectum. Results During the period of analysis, 1876 patients were operated on for a fistula. Of these, 82 (4.4%) had a horseshoe extension. The majority (72%) were male and the median age was 46 (17–84) years. The primary tract was high transsphincteric in 90% of cases and the primary opening was posterior in 65% of cases. The location of the horseshoe extension was posterior in 66% of cases with spread in the deep perianal space in 62%. In all, 71% were cryptoglandular and 24% were seen in Crohn’s disease (20). Of the 62 non‐Crohn’s patients previous treatment was common and included surgery (42), antibiotics alone (41) and non‐steroidal anti‐inflammatory drugs (21). Conclusion Horseshoe extension in anal fistula is uncommon. With Crohn’s disease excepted, the majority had had previous treatment.  相似文献   
2.
Horseshoe extensions in anal fistulas are uncommon but represent a challenging condition for their management. They are associated with substantial morbidity and carry a significant risk of anal incontinence. First operative time needs to address the drainage of the horseshoe extension and following operations are for main fistula track. Sphincter sparing techniques are conceivable but their efficacy has not been specifically assessed in this situation.  相似文献   
3.
Allopurinol hypersensitivity syndrome (AHS) is a severe drug reaction. It is characterized by rash, fever, and internal organ involvement. It may present in different clinical forms. We present a case of acute generalized exanthematous pustulosis occurring as a manifestation of AHS.KEY WORDS: Allopurinol, hypersensitivity syndrome, pustulosis  相似文献   
4.
The administration of therapeutic proteins via the subcutaneous route (sc) is desired for compliance and convenience, but could be challenging due to perceived immunogenic potential or unwanted immune responses. There are clinical and preclinical data supporting as well as refuting the generalized notion that sc is more immunogenic. We provide a mechanistic perspective of immunogenicity of therapeutic proteins administered via the sc route and discuss strategies and opportunities for novel therapeutic approaches to mitigate immunogenicity.  相似文献   
5.
The human leukocyte antigens (HLA) may influence host immune to infection. In the mean time chronic hepatitis C (CHC) results in the appearance of a variety of autoantibodies. We investigated the frequency of circulating anti-HLA antibodies and none organ specific autoantibodies in patients with chronic hepatitis C at different stages of disease activity. Sixty-seven untreated male patients with CHC (anti-HCV antibody and HCV RNA positive), in whom 38 had elevated serum alanine aminotransferase (ALT) levels and 29 persistently normal serum ALT values, and 23 age-matched normal male subjects were studied. None of them had a history of blood transfusion. Sera were analyzed for immunoglobulin G-anti-HLA class I and class II antibodies by enzyme-linked immunosorbant assay, and for non-organ-specific autoantibodies (antinuclear, anti-smooth muscle, anti-mitochondrial and anti-liver/kidney microsomes type 1 antibodies) using indirect immunofluorescence technique. Circulating anti-HLA class I and class II antibodies were detected in 15/67 (22.4 %) and 11/67 (16.4 %) respectively, while none of normal controls had detectable anti-HLA antibodies in the serum. The frequency of detecting anti-HLA antibodies was significantly higher in patients with elevated serum ALT than persistently normal serum ALT values (31.6 % vs 10.3 %; P = 0.039) and was associated with non-organ-specific serum autoantibodies in 11/15 (73.3 %) patients. Those with circulating anti-HLA antibodies had significantly higher levels of serum aminotransferases, gamma-glutamyl transpeptidase, viral load and necroinflammatory and fibrosis scores in liver biopsies than patients with negative anti-HLA antibody (P < 0.001). In conclusions, the presence of circulating antibodies against HLA class I and class II molecules in HCV antibodies may represent an autoimmune response to HLA antigens and may play a pathogenetic role in the induction of the HCV-related chronic liver disease.  相似文献   
6.
Spindler  L.  Alam  A.  Fathallah  N.  Rentien  A.-L.  Draullette  M.  Pommaret  E.  Thierry  M.-L.  Mituialy  A. El  Abbes  L.  Aubert  M.  Benfredj  P.  Far  E. Safa  Beaussier  H.  de Parades  V. 《Techniques in coloproctology》2022,26(2):143-146
Techniques in Coloproctology - The aim of our study was to assess the efficacy of sinus laser therapy (SiLaT) for the treatment of pilonidal disease. All adult patients treated with SiLaT in our...  相似文献   
7.
8.
9.
Haplotype analysis using microsatellite markers is a useful indicator of specific mutations and is often exploited as the first large-scale screening technique to carry out the molecular characterization of the disease gene in probands from a specific population. However, the methodologies available are still cumbersome and require the use of either radioactive compounds or specialized equipment suitable to follow fluorescent dyes. Both these techniques may not be available for newly developing clinical laboratories. We have set up a sensitive and easy-to-use protocol to characterize five closely spaced, highly polymorphic microsatellite polymorphisms (CA repeats) that span the Wilson disease (WD) region, i.e. D13S316, D13S133, D13S301, D13S314, D13S315. The technique described here for the analysis of the WD gene microsatellite system relies on the quick detection method of silver staining, avoiding the use of toxic or sophisticated equipment. This approach could be the method of choice to implement molecular genetic testing in clinical laboratories, even those not especially equipped for DNA analysis and in particular in newly developed molecular genetics centers in countries whose population has not yet been characterized for WD-causing ATP7B gene mutations.  相似文献   
10.

Introduction

In Tunisia, asymptomatic carriage of Leishmania is poorly documented.

Objective

The aim of the present study was to estimate the frequency of asymptomatic infection among the family members of patients with patent visceral leishmaniasis by using the Western blotting kit based on 14 and 16 kDa bands.

Material and methods

We tested 94 sera collected from 24 patients with patent visceral leishmaniasis and 70 from their families’ members.

Results

The rate of seropositivity was 100% in the group of patients and 54.3% in the group of families’ members. The analysis of the Western blotting patterns showed that the 33 kDa, 24 kDa and to a lesser extent the 22 kDa band were very indicative of patent visceral leishmaniasis in contrast to asymptomatic infection where these bands were very rarely detected.

Conclusion

The results reported herein showed the high frequency of asymptomatic carriers of Leishmania among the families’ members of visceral leishmaniasis cases and the usefulness of the Western blotting as a screening technique and in distinguishing between patent visceral leishmaniasis and the asymptomatic carriage of Leishmania.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号